MIRAMAR, Fla., May 06, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company ...
MIRAMAR, Fla., May 11, 2021 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (“Generex” or the “Company”), an innovative and integrated healthcare holding company ...
Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that it has entered into a non-binding Letter of Intent (LOI) with Hema Diagnostic Systems, LLC (HDS) ...
Generex Biotechnology Corporation, engaged in the research, development, and commercialisation of drug delivery systems and technologies, has entered into a non-binding letter of intent (LOI) with ...
WORCESTER, Mass., Jan. 25, 2011 /PRNewswire/ -- Generex Biotechnology Corporation (the "Company") (www.generex.com) (OTC Bulletin Board: GNBT) today announced that it entered into a securities ...
Generex Biotechnology Corporation, a company engaged in the research, development, and commercialization of drug delivery systems and technologies, has entered into a non-binding Letter of Intent (LoI ...
NuGenHealth Software as a Service (SaaS) platform that enables their clients to monitor the health and wellbeing of their patient population. Westside Medicine & Cardiology, Inc. is a professional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results